Collateral for a security interest recorded Nov 17, 2023 (Ankura Trust Company, LLC).
Term ends Nov 27, 2042 · High confidence
20-year base term ends Apr 28, 2040
Held by Ribon Therapeutics, Inc.
Filed Oct 28, 2021 as application 17/607,090 · Granted Jul 29, 2025
Base term plus 943 days of patent term adjustment (USPTO delay)
Today
2020
2042
Clock starts
Apr 28, 2020
Apr 28, 2020
Term ends
Nov 27, 2042
Nov 27, 2042
Granted
Jul 29, 2025
Jul 29, 2025
base term
patent term adjustment
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
943
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 943 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 28, 2020, when application PCT/US2020/030263, the earliest non-provisional in its chain, was filed (this one was filed Oct 28, 2021) | Apr 28, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +943 days, USPTO patent term adjustment record | Nov 27, 2042 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 27, 2042 | High confidence |
This family
| Application PCT/US2020/030263 | PCT application no patent term | no patent term |
| US 12,371,421 | this patent Nov 2042 | Nov 2042 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 14, 2021 Reel 58386, frame 953 | Xu, Jun; Jiang, Meng; He, Xin | Crystal Pharmatech Co., Ltd. | Assignment of Assignor's Interest |
| Dec 14, 2021 Reel 58387, frame 56 | Crystal Pharmatech Co., Ltd. | Ribon Therapeutics, Inc. | Assignment of Assignor's Interest |
| Dec 14, 2021 Reel 58386, frame 858 | Vasbinder, Melissa Marie; Schenkel, Laurie B.; Swinger, Kerren Kalai; Kuntz, Kevin Wayne | Ribon Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 17, 2023 Reel 65607, frame 551 | Ribon Therapeutics, Inc. | Ankura Trust Company, LLC, as Collateral Trustee | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2042
Term ends Nov 27, 2042. Maintenance fees still fall due before then
Note
The 943 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.